A new year brings a fresh Fierce Biotech Fundraising Tracker designed to record the significant amount of venture capital that flows into biopharma. We’re keeping the same guidelines used for last year’s tracker and will only include financing rounds of $50 million and above. April April 10—Vivatides Therapeutics Series: A Amount: $54M Investors: Qiming Venture Partners, Highlight Capital, TF Capi...